SPDB-DM4 is a part of the ADC. It is composed of DM1 (a microtubule inhibitor, also an antibody-encodable aristolochic acid alkaloid, used to overcome the systemic toxicity associated with aristolochic acid and enhance tumor-specific delivery) and SPDB, and exhibits highly efficient anti-tumor activity.
* VAT and and shipping costs not included. Errors and price changes excepted